Long-Term Outcomes of 1989 Immediate Implant-Based Breast Reconstructions: An Analysis of Risk Factors for Failure and Revision Surgery
- PMID: 39315798
- PMCID: PMC11845074
- DOI: 10.1097/PRS.0000000000011744
Long-Term Outcomes of 1989 Immediate Implant-Based Breast Reconstructions: An Analysis of Risk Factors for Failure and Revision Surgery
Abstract
Background: Nipple- or skin-sparing mastectomy and immediate implant-based breast reconstruction (IBR) is potentially associated with long-term unfavorable outcomes, such as revision surgery and reconstruction failure. This large patient cohort study aimed to provide long-term data on the incidence of these outcomes and to identify predictive risk factors.
Methods: Between 2012 and 2019, 1989 mastectomies with IBR were performed in 1512 women in the authors' institute. A direct-to-implant method was used in 93% and a 2-staged method with tissue expander in 7%. Logistic regression analysis was used to identify patient- and treatment-related risk factors associated with revision surgery or reconstructive failure.
Results: The mean follow-up was 62.2 months. IBR failed in 6.7% of all breasts; thus, a breast was present in 93.3%. Age older than 44 years yielded a 2.6-fold, and radiotherapy, a 1.7-fold increased risk for reconstruction failure. Revision surgery was performed in 60% of all breasts. The mean number of revisions of all IBRs was 1.2 (range, 0 to 8; SD, 1.37). Factors associated with significantly higher rates of revision surgery were age older than 44 years (OR, 1.23), smoking (OR, 1.53), specimen weight greater than 492 g (OR, 1.39), implant volume greater than 422 g (OR, 1.95), and radiotherapy (OR, 1.51). Nipple preservation was protective for both outcomes (OR, 0.71 and 0.42, respectively). Direct-to-implant procedures did not require any surgical revision in 43% of these patients.
Conclusions: Despite the necessity of revision surgery in the majority of IBRs, nearly half of the breasts did not require any revision surgery, and long-term reconstruction failure rates are extremely low. Therefore, IBR should be offered to all eligible women undergoing mastectomy, while understanding the risks.
Clinical question/level of evidence: Risk, III.
Copyright © 2024 The Authors. Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Plastic Surgeons.
Conflict of interest statement
The authors have no conflicts of interest to declare.
Figures
References
-
- Federatie Medisch Specialisten Nederland, Nederlandse Vereniging van Plastische Chirurgie. Richtlijn Borstreconstructie: Reconstructietechnieken bij ablatieve behandeling. Published April 8, 2019. Available at: https://richtlijnendatabase.nl/richtlijn/borstreconstructie/reconstructi.... Accessed November 16, 2023.
-
- IKNL. Borstkanker in Nederland: incidentie, behandeling en overleving 1989-2021 o.b.v. de Nederlandse Kankerregistratie. https://iknl.nl/borstkankercijfers. Accessed November 16, 2023.
-
- NICE. Early and locally advanced breast cancer: diagnosis and management: guideline. Updated July 2018. Available at: https://www.nice.org.uk/guidance/ng101/resources/early-and-locally-advan.... Accessed November 16, 2023.
-
- Merchant SJ, Goldstein L, Kruper LL. Patterns and trends in immediate postmastectomy reconstruction in California: complications and unscheduled readmissions. Plast Reconstr Surg. 2015;136:10e–19e. - PubMed
-
- Flitcroft K, Brennan M, Spillane A. Making decisions about breast reconstruction: a systematic review of patient-reported factors influencing choice. Qual Life Res. 2017;26:2287–2319. - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
